Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 736

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 736
---
| Notes to Condensed Consolidated Financial Statements                                                                      | ​ | ​ | ​    | ​ | F-7 | ​ | ​ |

| ​                                                                                                          | ​ | ​ | Page |   |      |   | ​ |
| Financial Statements:                                                                                      | ​ | ​ | ​    | ​ | ​    | ​ | ​ |
| Reports of Independent Registered Public Accounting Firm (PCAOB ID: 42)                                    | ​ | ​ | ​    | ​ | F-34 | ​ | ​ |
| Consolidated Balance Sheets as of December 31, 2023 and 2022                                               | ​ | ​ | ​    | ​ | F-37 | ​ | ​ |
| Consolidated Statements of Comprehensive Loss for the years ended December 31, 2023, 2022 and 2021         | ​ | ​ | ​    | ​ | F-38 | ​ | ​ |
| Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2023, 2022, 2021 and 2020 | ​ | ​ | ​    | ​ | F-39 | ​ | ​ |
| Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021                 | ​ | ​ | ​    | ​ | F-40 | ​ | ​ |
| Notes to Consolidated Financial Statements                                                                 | ​ | ​ | ​    | ​ | F-41 | ​ | ​ |

TVARDI THERAPEUTICS, INC.

| ​                                                                                                                           
 Report of Independent Registered Public Accounting Firm                                                                     
 Balance sheets as of December 31, 2023 and 2022                                                                             
 Statementsof Operations and Comprehensive Loss for the Years EndedDecember 31, 2023 and 2022                                | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | Page 
 ​    
 ​    
 ​    | ​ 
 ​ 
 ​ | F-89 
 F-91 
 F-92 | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ |
|:----------------------------------------------------------------------------------------------------------------------------|:--|:--|:-----|:--|:-----|:--|:--|
| Statements ofRedeemable Convertible Preferred Stock and Stockholders’ Deficit for the Years EndedDecember 31, 2023 and 2022 | ​ | ​ | ​    | ​ | F-93 | ​ | ​ |
| Statement